https://www.selleckchem.com/pr....oducts/diphenhydrami
There are about 60,000 diagnoses of cancer per year in Belgium. After hospital care, about 12-13% of cancer patients are readmitted within 30days after discharge. These readmissions are partly related to drug-related problems (DRP), such as interactions or adverse drug effects (ADE). The aim of this study is to quantify and to classify DRP readmissions within 30days for cancer patients and to highlight risk factors potentially correlated to readmissions. This study is a 6-month observational retrospective study in two care facil
إعجاب
علق
شارك
